VEGFA and neoplasm: Thus, inhibition of the VEGF pathway can attenuate bone marrow-derived CEPs mobilized by VEGF (37) and can trigger an increase in circulating mature CECs, reflecting sloughing of fragile mature endothelium, potentially from tumor vasculature (38, 39).